| Literature DB >> 34557940 |
Giovanni Marchegiani1, Giampaolo Perri2, Stefano Andrianello2, Gaia Masini2, Giacomo Brentegani2, Alessandro Esposito2, Claudio Bassi2, Roberto Salvia2.
Abstract
PURPOSE: No accepted benchmarks for open pancreaticoduodenectomy (PD) exist. The study assessed the time to functional recovery after open PD and how this could be affected by the magnitude of midline incision (MI).Entities:
Keywords: Benchmark; Functional recovery; Midline incision; Minimally invasive; Open; Pancreatoduodenectomy
Mesh:
Year: 2021 PMID: 34557940 PMCID: PMC9151571 DOI: 10.1007/s00423-021-02333-3
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 2.895
Fig. 1A Short midline incision covers < 60% of the xipho-pubic distance (*), B long midline incision covers ≥ 60% of xipho-pubic distance (*)
Benchmark time to functional recovery after PD (n = 249)
| Overall | ||
|---|---|---|
| Length of stay (days, median, IQR) | 11 (19) | |
| Time to functional recovery (days, median, IQR) | 7 (9) | |
| Item | Pain control (days, median, IQR) | 4 (2) |
| Mobility (days, median, IQR) | 5 (2) | |
| Oral food intake (days, median, IQR) | 6 (7) | |
| Absence of signs of infection (days, median, IQR) | 5 (7) | |
IQR, interquartile range
Fig. 2Kaplan–Meier curves showing the cumulative TtFR achievement for the entire cohort
Perioperative characteristics stratified for length of MI in uncomplicated patients (n = 124)
| Overall | SMI | LMI | |||
|---|---|---|---|---|---|
| Age (years, median, IQR) | 65 (16) | 65 (13) | 65 (18) | 0.931 | |
| Sex | M | 61 (50.8%) | 29 (48.3%) | 32 (53.3%) | 0.715 |
| F | 59 (49.2%) | 31 (51.7%) | 28 (46.7%) | ||
| BMI (kg/m2, median, IQR) | 23.8 (4) | 23.3 (3.1) | 24.5 (5.7) | 0.040 | |
| Smoker | 30 (25%) | 20 (33.3%) | 10 (16.7%) | 0.057 | |
| Alcohol abuse | 1 (0.8%) | 1 (1.7%) | 0 | 1.000 | |
| Diabetes | 23 (19.2%) | 13 (21.7%) | 10 (16.7%) | 0.643 | |
| Ischemic cardiac disease | 2 (1.7%) | 1 (1.7%) | 1 (1.7%) | 1.000 | |
| Hypertension | 39 (32.5%) | 15 (25%) | 24 (40%) | 0.118 | |
| COPD | 0 | 0 | 0 | NA | |
| ASA score | 1 | 5 (4.2%) | 2 (3.3%) | 3 (5%) | 0.863 |
| 2 | 96 (80%) | 49 (81.7%) | 47 (78.3%) | ||
| 3 | 19 (15.8%) | 9 (15%) | 10 (16.7%) | ||
| Neoadjuvant treatment | 41 (34.2%) | 19 (31.7%) | 22 (36.7%) | 0.701 | |
| Epidural analgesia | 21 (17.5%) | 10 (16.7%) | 11 (18.3%) | 1.000 | |
| Vascular resection | 17 (14.3%) | 6 (10%) | 11 (18.6%) | 0.200 | |
| Stump texture | Hard | 75 (62.5%) | 43 (71.7%) | 32 (53.3%) | 0.059 |
| Soft | 45 (37.5%) | 17 (28.3%) | 28 (46.7%) | ||
| EBL (mL, median, IQR) | 530 (510) | 500 (455) | 550 (600) | 0.203 | |
| Main duct diameter (mm, median, IQR) | 4 (2) | 5 (3) | 4 (2) | 0.196 | |
| Operative time (min, median, IQR) | 420 (104) | 425 (109) | 420 (121) | 0.769 | |
| Fistula risk zone | Negligible | 5 (4.2%) | 3 (5%) | 2 (3.3%) | 0.157 |
| Low | 36 (30%) | 21 (35%) | 15 (25%) | ||
| Intermediate | 63 (52.5%) | 32 (53.3%) | 31 (51.7%) | ||
| High | 16 (13.3%) | 4 (6.7%) | 12 (20%) | ||
ASA, American Society of Anesthesiology; COPD, chronic obstructive pulmonary disease; BMI, body mass index; EBL, estimated blood loss; IQR, interquartile range
Time to functional recovery stratified for length of MI in uncomplicated patients (n = 124)
| Overall | SMI | LMI | |||
|---|---|---|---|---|---|
| Length of stay (days, median, IQR) | 7 (3) | 8 (3) | 7 (3) | 0.775 | |
| Time to functional recovery (days, median, IQR) | 6 (2) | 5 (2) | 6 (2) | 0.002 | |
| Items | Pain control (days, median, IQR) | 4 (1) | 4 (1) | 5 (1) | 0.048 |
| Mobility (days, median, IQR) | 4 (1) | 4 (1) | 5 (1) | 0.114 | |
| Oral food intake (days, median, IQR) | 5 (1) | 5 (2) | 6 (1) | 0.001 | |
| Absence of signs of infection (days, median, IQR) | 4 (1) | 4 (1) | 4 (1) | 0.830 | |
IQR, interquartile range
Fig. 3Kaplan–Meier curves showing the cumulative TtFR achievement for patients with Clavien-Dindo < 2 morbidity comparing SMI (blue) to LMI (green)